tiprankstipranks
BioCryst Shareholders Approve Expansion and Elect Directors
PremiumCompany AnnouncementsBioCryst Shareholders Approve Expansion and Elect Directors
1M ago
BioCryst Pharmaceuticals (NASDAQ:BCRX): A Value Opportunity with Growth Potential
PremiumMarket News
BioCryst Pharmaceuticals (NASDAQ:BCRX): A Value Opportunity with Growth Potential
1M ago
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
2M ago
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
PremiumPress ReleasesBioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
2M ago
BioCryst’s ORLADEYO approved in Mexico
PremiumThe Fly
BioCryst’s ORLADEYO approved in Mexico
2M ago
ORLADEYO® (berotralstat) Approved in Mexico
PremiumPress Releases
ORLADEYO® (berotralstat) Approved in Mexico
2M ago
BioCryst price target raised to $15 from $14 at JMP Securities
PremiumThe FlyBioCryst price target raised to $15 from $14 at JMP Securities
3M ago
BioCryst sees 2024 ORLADEYO revenue $390M-$400M
PremiumThe Fly
BioCryst sees 2024 ORLADEYO revenue $390M-$400M
3M ago
BioCryst expects total cash at end of 2024 to be above $300M
PremiumThe Fly
BioCryst expects total cash at end of 2024 to be above $300M
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100